Update, Phase 2 trial results: FC705 Outperforms Pluvicto
There we go, this is a great update! Pluvicto’s been the go-to standard, but new research like FC705 is totally blowing past it...
FC705, a new radioligand...
There we go, this is a great update! Pluvicto’s been the go-to standard, but new...